EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s share price fell 3.2% during mid-day trading on Friday . The stock traded as low as $21.85 and last traded at $22.12. 116,776 shares were traded during mid-day trading, a decline of 88% from the average session volume of 962,950 shares. The stock had previously closed at […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its target price reduced by HC Wainwright from $35.00 to $33.00 in a report released on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for EyePoint Pharmaceuticals’ Q4 2023 earnings at ($0.40) EPS, FY2023 earnings at ($1.89) […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 4,750,000 shares, a decrease of 32.2% from the November 30th total of 7,010,000 shares. Based on an average trading volume of 1,310,000 shares, […]
Insider Selling: EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Insider Sells 1,458 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) major shareholder Cormorant Asset Management, Lp purchased 588,235 shares of EyePoint Pharmaceuticals stock in a transaction dated Friday, December 8th. The stock was bought at an average price of $17.00 per share, with a total value of $9,999,995.00. Following the completion of the purchase, the insider now […]